[HTML] Phase I/II study exploring ImMucin, a pan‐major histocompatibility complex, anti‐MUC 1 signal peptide vaccine, in multiple myeloma patients

[HTML] Phase I/II study exploring ImMucin, a pan‐major histocompatibility complex, anti‐MUC 1 signal peptide vaccine, in multiple myeloma patients

L Carmon, I Avivi, R Kovjazin… - British journal of …, 2015 - Wiley Online Library

ImMucin, a 21‐mer cancer vaccine encoding the signal peptide domain of the MUC 1
tumour‐associated antigen, possesses a high density of T‐and B‐cell epitopes but
preserves MUC 1 specificity. This phase I/II study assessed the safety, immunity and clinical …

For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:

*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.

*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.

*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.

*Peptide Salt: TFA, Desalt, Acetate, HCl.

*Peptide Purity: From crude to ＞99.5%.

*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.

*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.

Quick Links:

Peptide Price
Peptide Modification
Peptide Library
Quote Request
Contact Us

Contact Information:

Eva He
eva@pepmic.com

Pepmic Co., Ltd
www.pepmic.com